Blog Posts

<a href="https://www.facebook.com/GlucoFit.Blood.Sugar.Ireland.All.Natural/">https://www.facebook.com/GlucoFit.Blood.Sugar.Ireland.All.Natural/</a>

Posted by dnna mayugh on September 24, 2024 at 11:42am 0 Comments

GlucoFit Blood Sugar Ireland

GlucoFit Blood Sugar Ireland is a supplement manufactured by the researchers at Phytage Labs that might help maintain healthy blood pressure levels while also reducing levels of cholesterol and triglycerides. It is possible to maintain people's blood pressure levels at a healthy and normal level with a supplement called GlucoFit Blood Sugar Ireland . As you become older, your blood vessels get narrower.

Click Here To Buy Now>>>…

Continue

DSYNC Staking

Posted by QKSEO on September 24, 2024 at 11:40am 0 Comments

https://destra.fi/
Destra Network Staking Dashboard | Stake $DSYNC and earn weekly rewards.

The Future of Online Casinos

Posted by kajal on September 24, 2024 at 11:33am 0 Comments



The online casino industry is constantly evolving, with new trends and technologies shaping the future of gaming. From virtual reality and augmented reality to blockchain technology and cryptocurrency, online casinos are embracing cutting-edge innovations to enhance the player experience. The future of online casinos promises to be exciting and full of possibilities, as… Continue

Vitamin D Market Latest Trends and Business Scenario 2030

Posted by Akash Ra on September 24, 2024 at 11:29am 0 Comments

Vitamin D Market size was valued at US$ 1.33 Bn. in 2023 and the total Vitamin D revenue is expected to grow by 7.8% from 2024 to 2030, reaching nearly US$ 2.25 Bn.

Vitamin D Market Report Scope and Research Methodology

The report is a thorough analysis of the Vitamin…

Continue

Hydroxychloroquine Drugs Market Report Analysis With Industry Share Insights Shared in Detailed Report

Hydroxychloroquine Drugs Market: Introduction




According to the report, the global hydroxychloroquine drugs market was valued at US$ 0.67 Bn in 2019 and is projected to expand at a CAGR of 10% from 2020 to 2030. Hydroxychloroquine belongs to a class of drugs called antimalarials. It is used to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system. In terms of disease indication, the global hydroxychloroquine drugs market has been classified into malaria, rheumatoid arthritis, COVID-19, systemic lupus erythematosus, and others. Based on distribution channel, the global hydroxychloroquine drugs market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The rise in prevalence of malaria and rheumatoid arthritis and increase in geriatric population augment the global hydroxychloroquine drugs market.




North America dominated the global hydroxychloroquine drugs market in 2019 and the trend is anticipated to continue during the forecast period. Well-established healthcare infrastructure and early adoption of advanced technologies are expected to boost the growth of the market in the region. Moreover, rise in prevalence of various types of targeted diseases increases demand for hydroxychloroquine drugs, which, in turn, fuels the growth of the market in North America. Asia Pacific is likely to be a highly lucrative market for hydroxychloroquine drugs during the forecast period. The market in the region is expected to grow rapidly over the next few years, due to increase in penetration and rise in awareness about biologic and biosimilar drug products in China. The country’s high market share can be attributed to the faster adoption of biologic and biosimilar drug products to treat chronic diseases such as rheumatoid arthritis and increase in geriatric population.




Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B...




High Prevalence of Malaria, Rheumatoid Arthritis, and Other Targeted Diseases to Drive Global Market




Hydroxychloroquine is FDA-approved to treat or prevent malaria. Hydroxychloroquine is also approved to treat autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis. According to the CDC, nearly half the world's population lives in areas at risk of malaria transmission in 91 countries and territories. In 2016, malaria caused an estimated 216 million clinical episodes and 445,000 deaths, which increased to an estimated 228 million cases and 405,000 deaths in 2018. Majority of deaths occurred in the WHO African Region. Systemic lupus erythematosus (SLE) is another most common autoimmune disease, in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. Hydroxychloroquine and corticosteroids (e.g., prednisone) are often used to treat SLE. The Lupus Foundation of America estimates that 1.5 million people in the U.S. and at least five million people across the world have a form of lupus. Ninety percent (90%) of people living with lupus are women.




Request a Sample of Hydroxychloroquine Drugs Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S...




Rheumatoid Arthritis to Dominate Global Market




In terms of disease indication, the global hydroxychloroquine drugs market has been bifurcated into malaria, rheumatoid arthritis, COVID-19, systemic lupus erythematosus, and others. The rheumatoid arthritis segment dominated the market in terms of revenue in 2019. The increase in geriatric population also fuels the growth of the segment. The prevalence varies between 0.3% and 1% and is more common in women and in developed countries, as per WHO data.




Hospital Pharmacies to be Key Distribution Channel




Based on distribution channel, the global hydroxychloroquine drugs market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the global hydroxychloroquine drugs market in 2019. Large inventory maintained by hospitals and availability of essential drugs at hospital pharmacies are expected to drive the segment from 2020 to 2030. However, the online pharmacies segment is likely to expand at the highest CAGR during the forecast period. Increase in adoption of eCommerce and convenience offered by online pharmacies pharmacies are projected to drive the online pharmacies segment during the forecast period.




Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=C...




North America to Dominate Global Market




The global hydroxychloroquine drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2019, followed by Europe. North America accounted for major share of the global hydroxychloroquine drugs market in 2019, owing to early adoption of advanced treatment option and well-established healthcare infrastructure and strategies adopted by key players. The hydroxychloroquine drugs market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030. The rise in prevalence of malaria across the region is projected to accelerate the growth of the market in the region.




Enquiry before Buying Hydroxychloroquine Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=E...




Competition Landscape




Zydus Cadilla, Novartis AG, and Prasco Laboratories are the three major companies operating in the global hydroxychloroquine drugs market. The global hydroxychloroquine drugs market is fragmented in terms of number of players. Key players in the global market include Sanofi, Amneal Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG, Zydus Cadila, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, and Prasco Laboratories. New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate business in the global hydroxychloroquine drugs market




More Trending Reports by Transparency Market Research:




https://www.prnewswire.com/news-releases/rise-in-the-demand-for-per...




https://www.prnewswire.com/news-releases/rising-demand-for-needle-f...




https://www.prnewswire.com/news-releases/surgical-microscopes-marke...




About Us 




Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.




Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.




For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ




Contact




Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Websitehttps://www.transparencymarketresearch.com
Bloghttps://tmrblog.com
Email: [email protected]

Views: 2

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service